Skip to main content
logo
Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.155
-0.035 (-2.94%)
Aug 28, 2026, 2:22 PM EDT - Market open

Milestone Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.341.55-1515
Revenue Growth
----80.00%-66.67%-
Gross Profit
2.31.55-1515
Operating Income
-78.38-62.14-42.1-61.1-59.64-43.07
Net Income
-84.01-63.06-41.52-59.69-58.39-42.85
Earnings Per Share
-0.71-0.75-0.67-1.39-1.38-1.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
170.61105.9669.76664.59114.14
Total Debt
141.8358.3854.851.782.490.7
Net Cash (Debt)
28.7847.5814.914.2362.09113.44
Net Cash Growth
-219.39%4.71%-77.09%-45.26%-19.75%
Net Cash Per Share
0.240.570.240.331.462.71

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-61.29-49.04-28.85-46.42-52.47-33.22
Capital Expenditures
-0.36-0.3-0.03-0.11-0.27-
Free Cash Flow
-61.65-49.34-28.88-46.54-52.74-33.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
98.04%100.00%-100.00%100.00%100.00%
Operating Margin
-3345.24%-4019.40%--6109.80%-1192.84%-287.15%
Pretax Margin
-3585.62%-4078.78%--5968.50%-1167.76%-285.69%
Profit Margin
-3585.62%-4078.78%--5968.50%-1167.76%-285.69%
FCF Margin
-2631.07%-3191.66%--4653.60%-1054.82%-221.49%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
71.57132.73-71.9133.8318.43